Sweet spoT for cArdiac Rhythm monitorinG After sTrokE (STARGATE)
Stroke, Atrial Fibrillation
About this trial
This is an interventional prevention trial for Stroke focused on measuring Implantable Loop Recorder, Anticoagulant, Stroke, Atrial fibrillation
Eligibility Criteria
Inclusion Criteria: - Adult patients with cortical or subcortical, cryptogenic or non-cryptogenic acute ischemic stroke Exclusion Criteria: AF on 24-h inpatient or Holter monitoring Atrial or ventricular thrombus Other major-risk cardioembolic sources (e.g., mechanical valve) Other indications (e.g., venous thromboembolism) or contraindications for OACs.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Disclosure
Non-Disclosure
Group A (disclosure arm): patients and physicians will be informed about all AF episodes identified on ILR lasting for ≥6 minutes.
Group B (non-disclosure arm): patients and physicians will be only informed about AF episodes identified on ILR lasting for ≥24h. This longer threshold is selected because of its association with increased risk of systemic embolism.